4.3 Article

Association of Change in Smoking Status and Subsequent Weight Change with Risk of Nonalcoholic Fatty Liver Disease

Journal

GUT AND LIVER
Volume -, Issue -, Pages -

Publisher

EDITORIAL OFFICE GUT & LIVER
DOI: 10.5009/gnl220038

Keywords

Nonalcoholic fatty fiver; Screening; Fatty liver index; Smoking cessation; Cohort study

Funding

  1. National Research Foundation of Korea (NRF) - Korea government (MSIT)
  2. SNUH Research Fund
  3. [2021R1F1A1063346]
  4. [04-2021-0370]

Ask authors/readers for more resources

Weight change after a change in smoking status is associated with the risk of NAFLD. Weight gain increases NAFLD risk in smoking cessation, smoking relapse, and sustained smoking groups, while weight loss reduces NAFLD risk. Smoking cessation and sustained smoking are also associated with higher NAFLD risk in participants with no BMI change, and liver enzyme levels are higher in participants with smoking cessation and BMI gain. Monitoring and managing weight change after a change in smoking status may help reduce NAFLD risk.
Background/Aims: Smoking is considered a risk factor for the development of nonalcoholic fatty liver disease (NAFLD). However, the association of a weight change after a change in smoking status and the risk of NAFLD remains undetermined. Methods: This study used the Korean National Health Insurance Service-National Sample Cohort. Based on the first (2009 to 2010) and second (2011 to 2012) health examination periods, 139,180 adults aged at least 40 years were divided into nonsmoking, smoking cessation, smoking relapse, and sustained smoking groups. NAFLD was operationally defined using the fatty liver index. The adjusted odds ratio (aOR) and 95% confidence interval (CI) were calculated using multivariable-adjusted logistic regression. Results: Compared to nonsmoking with no body mass index (BMI) change, the risk of NAFLD was significantly increased among subjects with BMI gain and nonsmoking (aOR, 4.07: 95% Cl. 3.77 to 4.39), smoking cessation (aOR, 5.52; 95% CI, 4.12 to 7.40), smoking relapse (aOR, 7.51; 95% CI, 4.81 to 11.72), and sustained smoking (aOR, 6.65; 95% CI, 5.33 to 8.29), whereas the risk of NAFLD was reduced among participants with BMI loss in all smoking status groups. In addition, smoking cessation (aOR, 1.76; 95% CI, 1.35 to 2.29) and sustained smoking (aOR, 1.64; 95% CI, 1.39 to 1.94) were associated with higher risk of NAFLD among participants with no BMI change. The liver enzyme levels were higher among participants with smoking cessation and BMI gain. Conclusions: Monitoring and management of weight change after a change in smoking status may be a promising approach to reducing NAFLD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available